Elixxer Ltd (ELXR) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.024x

Based on the latest financial reports, Elixxer Ltd (ELXR) has a cash flow conversion efficiency ratio of 0.024x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-367.24K ≈ $-265.66K USD) by net assets (CA$-15.05 Million ≈ $-10.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Elixxer Ltd fund operations to measure how many days the company can operate on defensive assets alone.

Elixxer Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Elixxer Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Elixxer Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Elixxer Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Arecor Therapeutics PLC LSE:AREC	-0.178x
East Star Resources PLC LSE:EST	-0.884x
Sino-German United AG F:SGU	N/A
Global PVQ SE HM:QCE	3.126x
Altair Resources Inc V:AVX	0.002x
Shuttle Pharmaceuticals Inc NASDAQ:SHPH	-0.722x
Annum Bhd KLSE:5082	0.001x
Provexis plc LSE:PXS	-0.584x

Annual Cash Flow Conversion Efficiency for Elixxer Ltd (2017–2024)

The table below shows the annual cash flow conversion efficiency of Elixxer Ltd from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see Elixxer Ltd market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$-13.09 Million ≈ $-9.47 Million	CA$0.00 ≈ $0.00	0.000x	--
2023-12-31	CA$-9.60 Million ≈ $-6.94 Million	CA$-2.40 Million ≈ $-1.74 Million	0.250x	-53.81%
2022-12-31	CA$-5.58 Million ≈ $-4.04 Million	CA$-3.02 Million ≈ $-2.19 Million	0.541x	+212.79%
2021-12-31	CA$8.38 Million ≈ $6.06 Million	CA$-4.02 Million ≈ $-2.91 Million	-0.480x	+24.26%
2020-12-31	CA$4.76 Million ≈ $3.44 Million	CA$-3.01 Million ≈ $-2.18 Million	-0.633x	-148.31%
2018-12-31	CA$17.67 Million ≈ $12.79 Million	CA$-4.51 Million ≈ $-3.26 Million	-0.255x	+84.87%
2017-12-31	CA$1.58 Million ≈ $1.14 Million	CA$-2.66 Million ≈ $-1.92 Million	-1.685x	--

About Elixxer Ltd

V:ELXR Canada Drug Manufacturers - Specialty & Generic

Market Cap

$287.08K

CA$396.86K CAD

Market Cap Rank

#31021 Global

#1669 in Canada

Share Price

CA$0.04

Change (1 day)

+0.00%

52-Week Range

CA$0.03 - CA$1.15

All Time High

CA$99.00